Cencora, Inc. (COR) is a publicly traded Healthcare sector company. As of August 25, 2026, COR trades at $323.92 with a market cap of $60.69B and a P/E ratio of 156.63. COR moved +0.05% today. Year to date, COR is -4.14%; over the trailing twelve months it is +10.65%. Its 52-week range spans $223.92 to $377.54. Analyst consensus is strong buy with an average price target of $369.18. Rallies surfaces COR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
12 analysts cover COR: 0 strong buy, 9 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $369.18.
| Metric | Value |
|---|---|
| Price | $323.92 |
| Market Cap | $60.69B |
| P/E Ratio | 156.63 |
| EPS | $2.06 |
| Dividend Yield | 0.60% |
| 52-Week High | $377.54 |
| 52-Week Low | $223.92 |
| Volume | 69 |
| Avg Volume | 0 |
| Revenue (TTM) | $638.56M |
| Net Income | $99.92M |
| Gross Margin | 0.00% |
12 analysts cover COR: 0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $369.18.